The role of substance P in epilepsy and seizure disorders
- PMID: 29100462
- PMCID: PMC5652851
- DOI: 10.18632/oncotarget.20606
The role of substance P in epilepsy and seizure disorders
Erratum in
-
Correction: The role of substance P in epilepsy and seizure disorders.Oncotarget. 2019 May 28;10(37):3576. doi: 10.18632/oncotarget.26991. eCollection 2019 May 28. Oncotarget. 2019. PMID: 31191827 Free PMC article.
Abstract
A range of evidence implicates the neuropeptide substance P (SP), a member of the tachykinin family, in emotional behavior, anxiety, pain, and inflammation. Recently, SP has been implicated in susceptibility to seizures, for which a potential proconvulsant role was indicated. Indeed, antagonists of a specific SP receptor, neurokinin-1 receptor, were found to attenuate kainic acid (KA)-induced seizure activity. However, detailed mechanisms of SP regulation in epilepsy remain obscure. In this review, we summarize the present literature to expound the role of SP in epilepsy, and provide hypotheses for potential mechanisms.
Keywords: epilepsy; inflammation; neuron; substance P.
Conflict of interest statement
CONFLICTS OF INTEREST The authors confirm that this article content has no conflicts of interest.
Similar articles
-
A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity.Brain Res Mol Brain Res. 1998 Oct 1;60(2):291-5. doi: 10.1016/s0169-328x(98)00191-0. Brain Res Mol Brain Res. 1998. PMID: 9757066
-
Dexamethasone after early-life seizures attenuates increased susceptibility to seizures, seizure-induced microglia activation and neuronal injury later in life.Neurosci Lett. 2020 May 29;728:134953. doi: 10.1016/j.neulet.2020.134953. Epub 2020 Apr 9. Neurosci Lett. 2020. PMID: 32278942
-
Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors.Brain Res. 2008 Feb 8;1193:153-61. doi: 10.1016/j.brainres.2007.12.017. Epub 2007 Dec 15. Brain Res. 2008. PMID: 18178179
-
Substance P Regulation in Epilepsy.Curr Neuropharmacol. 2018;16(1):43-50. doi: 10.2174/1570159X15666170504122410. Curr Neuropharmacol. 2018. PMID: 28474564 Free PMC article. Review.
-
Substance P and the Neurokinin-1 Receptor: The New CRF.Int Rev Neurobiol. 2017;136:151-175. doi: 10.1016/bs.irn.2017.06.008. Epub 2017 Aug 18. Int Rev Neurobiol. 2017. PMID: 29056150 Review.
Cited by
-
Capsaicin Exerts Anti-convulsant and Neuroprotective Effects in Pentylenetetrazole-Induced Seizures.Neurochem Res. 2020 May;45(5):1045-1061. doi: 10.1007/s11064-020-02979-3. Epub 2020 Feb 8. Neurochem Res. 2020. PMID: 32036609
-
Substance P-Friend or Foe.J Clin Med. 2022 Jun 22;11(13):3609. doi: 10.3390/jcm11133609. J Clin Med. 2022. PMID: 35806893 Free PMC article.
-
The Neuropathic Itch Caused by Pseudorabies Virus.Pathogens. 2020 Mar 31;9(4):254. doi: 10.3390/pathogens9040254. Pathogens. 2020. PMID: 32244386 Free PMC article. Review.
-
Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases.Biomedicines. 2022 Feb 1;10(2):343. doi: 10.3390/biomedicines10020343. Biomedicines. 2022. PMID: 35203552 Free PMC article. Review.
-
Changes in the Dentate Gyrus Gene Expression Profile Induced by Levetiracetam Treatment in Rats with Mesial Temporal Lobe Epilepsy.Int J Mol Sci. 2024 Jan 30;25(3):1690. doi: 10.3390/ijms25031690. Int J Mol Sci. 2024. PMID: 38338984 Free PMC article.
References
-
- Li B, Tang F, Wang L, Liu L, Zhao J, Zhou Y, Wang Y, Song Y, Li Y, Cui R. Anticonvulsant effects of Fuzi total alkaloid on pentylenetetrazole-induced seizure in mice. J Pharmacol Sci. 2013;123:195–8. - PubMed
-
- Ge T, Yang W, Fan J, Li B. Preclinical evidence of ghrelin as a therapeutic target in epilepsy. Oncotarget. 2017;8:59929–39. https://doi.org/10.18632/oncotarget.18349. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources